Enzo Biochem, Inc. (ENZB)
OTCMKTS · Delayed Price · Currency is USD
0.69887
+0.01137 (1.65%)
Inactive · Last trade price on Aug 19, 2025
Enzo Biochem Revenue
Enzo Biochem had revenue of $6.40M in the quarter ending April 30, 2025, a decrease of -20.19%. This brings the company's revenue in the last twelve months to $27.47M, down -17.59% year-over-year. In the fiscal year ending July 31, 2024, Enzo Biochem had annual revenue of $31.91M with 2.72% growth.
Revenue (ttm)
27.47M
Revenue Growth
-17.59%
P/S Ratio
1.33
Revenue / Employee
209.73K
Employees
136
Market Cap
36.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 31.91M | 846.00K | 2.72% |
| Jul 31, 2023 | 31.06M | -1.58M | -4.85% |
| Jul 31, 2022 | 32.64M | -85.09M | -72.27% |
| Jul 31, 2021 | 117.73M | 41.71M | 54.87% |
| Jul 31, 2020 | 76.02M | -5.15M | -6.34% |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Enzo Biochem News
- 1 year ago - Battery Ventures Completes Take-Private of Enzo Biochem - Business Wire
- 1 year ago - ENZO BIOCHEM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enzo Biochem, Inc. - ENZB - Business Wire
- 1 year ago - Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction - GlobeNewsWire
- 1 year ago - Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results - GlobeNewsWire
- 1 year ago - Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction - GlobeNewsWire
- 1 year ago - Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX - GlobeNewsWire
- 1 year ago - Enzo Biochem Reports Second Quarter Fiscal Year 2025 Results - GlobeNewsWire
- 1 year ago - Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules - GlobeNewsWire